These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10528789)

  • 1. Fusidic acid non-antibacterial activity.
    Christiansen K
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S73-8. PubMed ID: 10528789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusidic acid for Behçet's colitis: a novel approach to T-cell specific immunosuppressive therapy.
    Langholz E; Brynskov J; Freund LG; Bendtzen K
    Dan Med Bull; 1991 Jun; 38(3):284. PubMed ID: 1868757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV replication in vitro by fusidic acid.
    Faber V; Dalgleish AG; Newell A; Malkovsky M
    Lancet; 1987 Oct; 2(8563):827-8. PubMed ID: 2443777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin.
    Langholz E; Brynskov J; Bendtzen K; Vilien M; Binder V
    Aliment Pharmacol Ther; 1992 Aug; 6(4):495-502. PubMed ID: 1420741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behçet's disease associated with Crohn's disease].
    Houman H; Ben Dahmen F; Ben Ghorbel I; Chouaib S; Lamloum M; Kchir N; Ben Ammar A; Miled M
    Ann Med Interne (Paris); 2001 Nov; 152(7):480-2. PubMed ID: 11965089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusidic acid and insulin-dependent diabetes mellitus.
    Nicoletti F; Meroni PL; Bendtzen K
    Autoimmunity; 1996; 24(3):187-97. PubMed ID: 9020411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bile salts and of fusidic acid on HIV-1 infection of cultured cells.
    Lloyd G; Atkinson T; Sutton PM
    Lancet; 1988 Jun; 1(8600):1418-21. PubMed ID: 2898581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment.
    Yamada Y; Sugita S; Tanaka H; Kamoi K; Takase H; Mochizuki M
    Br J Ophthalmol; 2011 Feb; 95(2):205-8. PubMed ID: 20542984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thalidomide--a new prospective therapy in rheumatology and transplantation].
    Pałgan K; Pałgan I; Dziedziczko A
    Wiad Lek; 2003; 56(11-12):574-6. PubMed ID: 15058168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.
    Lee RW; Dick AD
    Br J Ophthalmol; 2010 Mar; 94(3):269-70. PubMed ID: 20215370
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS; Gavin MP; Sturrock RD
    Adv Exp Med Biol; 2003; 528():557-9. PubMed ID: 12918763
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series.
    Emmi G; Silvestri E; Ciucciarelli L; Squatrito D; Emmi L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S172. PubMed ID: 24709082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive agents in rheumathology].
    Dorfmann H; Dreyfus P
    Cah Coll Med Hop Paris; 1969 Oct; 10(12):1014-6. PubMed ID: 5308521
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of anakinra in refractory Behçet's disease sacroiliitis.
    Caso F; Rigante D; Vitale A; Lucherini OM; Cantarini L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S171. PubMed ID: 24709061
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of fusidic acid on migration and chemiluminescence of polymorphonuclear leukocytes.
    Naess A; Flø RW; Solberg CO
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):42-4. PubMed ID: 2303066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
    Niessen F; Campinchi R; Bloch-Michel E
    J Fr Ophtalmol; 1982; 5(6-7):407-16. PubMed ID: 7130629
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ocular manifestations of Behçet's disease.
    Davatchi F
    Adv Exp Med Biol; 2003; 528():487-91. PubMed ID: 12918750
    [No Abstract]   [Full Text] [Related]  

  • 19. Eye and Behçet's disease.
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Apr; 42(4):e133-e146. PubMed ID: 30850197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusidic acid and human phagocyte function.
    Kharazmi A; Nielsen H
    J Antimicrob Chemother; 1988 Aug; 22(2):262-3. PubMed ID: 3182420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.